NASDAQ:MRKR

Marker Therapeutics Stock News

etoro logo Buy MRKR
*Your capital is at risk
$1.45
+0.0300 (+2.11%)
At Close: Jun 03, 2026
Calls are being made for "positive action" to address the issue
Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological ma
The government is trying to paint teachers as part of an enemy elite, says the Guardian columnist Zoe Williams
Cancer therapeutics biotech Immutep (ASX:IMM) has enrolled and dosed the last patient for a segment of its phase 2 study into cancer treatments. The recruitment and dosing milestone was for stage 2 of
Shadow education ministers Emma Hardy and Tulip Siddiq are currently the bookies' favourites to replace Rebecca Long-Bailey

England class sizes largest in nearly 20 years

05:03pm, Thursday, 25'th Jun 2020
Official data shows baby boom decade pushed average secondary school class to 22 pupils
"When the Minister announced it we thought she must have a plan. There was no plan"
SCHOOLS will reopen in September under plans by Boris Johnson - but education unions have attacked the Prime Minister's plans as a "pure fantasy".
LAURA BRIGGS is suspicious of the government’s allocation of public funding to establish a ‘national tutoring programme’
Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological mal
A LABOUR run council has been accused of letting vulnerable children down by being the last to properly reopen schools in England.
Boris Johnson today announced a billion in cash to help pupils at risk fo falling behind because they've been shut out of lessons
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE